As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...

The $2.6 billion provider of specialty insurance and reinsurance, based in Maryland Heights, said it is realigning ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

The villains were injectable specialty drugs like Keytruda and inpatient surgical procedures for seriously ill patients.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...

Pharmacy Benefit Managers (PBM) sit in the center of our prescription drug system, coordinating between insurance companies, ...

The Federal Trade Commission on Jan. 14 published a second interim staff report on the prescription drug middleman industry, ...

The National Association of Chain Drug Stores released a video that explains how PBMs operate and how states and Congress are ...

GRAND JUNCTION, Colo. (KJCT) -A bipartisan bill was introduced into the house this week regarding healthcare costs for Coloradans. The bill introduced by Representatives Kyle Brown and Dusty Johnson ...

Known as the middlemen of the pharma industry, PBMs play an intermediary role between health insurers, pharmacies and patients, negotiating drug prices and designing formulary plans while mediating ...